| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.0003 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.0007 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.2 | 0.0008 |